Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Pharmacoepidemiology and Drug Safety|August 5, 2024
Risk of Suicidal Ideation and Behavior Following Early-Onset Idiopathic Restless Legs Syndrome TreatmentBrianna Costales, Scott M Vouri, Joshua D Brown, et al.Currents in Pharmacy Teaching & Learning|April 7, 2023
Enhancing active learning of medication errors in the PharmD curriculum through a multi-perspective video-based experienceJuan M Hincapie-Castillo, Ikenna F Unigwe, Scott M Vouri, et al.Journal of the American Pharmacists Association : Japha|June 17, 2023
Concomitant use of levothyroxine and interacting medications in U.S. ambulatory care visitsAlyssa L Dempsey, Grace Hsin-Min Wang, Naykky Singh Ospina, et al.Journal of Managed Care & Specialty Pharmacy|June 23, 2022
Patient out-of-pocket and payer costs for pegfilgrastim originator vs biosimilars as primary prophylaxis of febrile neutropenia in the first cycle among a commercially insured populationChing-Yu Wang, Haesuk Park, Coy D Heldermon, et al.Pharmacotherapy|June 29, 2023
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort studyMahek Garg, Veena Venugopalan, Scott M Vouri, et al.Journal of Managed Care & Specialty Pharmacy|January 27, 2023
Comparative effectiveness of pegfilgrastim biosimilars vs originator for prevention of febrile neutropenia: A retrospective cohort studyChing-Yu Wang, Scott M Vouri, Haesuk Park, et al.Journal of the American Geriatrics Society|October 27, 2022
Continued potassium supplementation use following loop diuretic discontinuation in older adults: An evaluation of a prescribing cascade relicGrace Hsin-Min Wang, Earl J Morris, Steven M Smith, et al.JAMA Network Open|June 11, 2021
Trends in Use of Prescription Nonsteroidal Anti-inflammatory Medications Before vs After Implementation of a Florida Law Restricting Opioid Prescribing for Acute PainShailina Keshwani, Ivanna Grande, Michael Maguire, et al.Current Medical Research and Opinion|August 25, 2021
The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010-2018Piaopiao Li, Rahul Patel, Jingchuan Guo, et al.Journal of Diabetes and Its Complications|July 12, 2021
Comparing cardiovascular benefits between GLP-1 receptor agonists and SGLT2 inhibitors as an add-on to metformin among patients with type 2 diabetes: A retrospective cohort studyChristina E DeRemer, Scott M Vouri, Jingchuan Guo, et al.Pageof 4